Journals / Abant Tıp Dergisi / 2017 / Cilt: 6 - Sayı: 2

Recent Advances in Kawasaki Disease

Kawasaki Hastalığında Güncel Gelişmeler

Pages
77–85
Publication Date
2017-05-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, diagnosis, treatment processes and prognostic features of Kawasaki disease, also an important cause of morbidity in our country, were discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Kawasaki disease is an acute febrile disease inchildren formerly known as mucocutaneous lymphnode disease or infantilepolyarteritis nodosa.
📊
Key Findings & Data:The disease, a systemic vasculitis of unknown etiology, in which the medium-sized blood vessels are affected, is frequently seen in children under five years of age.
💡
Conclusion & Impact:In this review, diagnosis, treatment processes and prognostic features of Kawasaki disease, also an important cause of morbidity in our country, were discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Kawasaki · mukokutanöz lenf nodu hastalığı · tedavi

Abstract

Kawasaki disease is an acute febrile disease inchildren formerly known as mucocutaneous lymphnode disease or infantilepolyarteritis nodosa. The disease, a systemic vasculitis of unknown etiology, in which the medium-sized blood vessels are affected, is frequently seen in children under five years of age. Organ systems, mainly the blood vessels, skin, mucous membranes, and lymph nodes are involved. The rarest but the most serious effect of the disease is on the heart, where it can cause fatal coronary artery aneurysms in untreated children. Therefore, early diagnosis, timely and appropriate treatment approach is very important. In this review, diagnosis, treatment processes and prognostic features of Kawasaki disease, also an important cause of morbidity in our country, were discussed.

Özet

Kawasaki hastalığı, daha önceleri mukokütanöz lenf nodu hastalığı veya infantil poliarteritis nodoza olarak da bilinen çocuklarda görülen akut febril bir hastalıktır. Hastalık, nedeni tam olarak bilinmeyen sistemik bir vaskülit olarak orta çaplı damar tutulumu ile seyreder ve çoğunlukla 5 yaş altı çocuklarda görülür. Kan damarları, cilt, muköz membranlar ve lenf nodları başta olmak üzere birçok organ sistemi etkilenir. En Nadir fakat en önemli etkilerinden biri kalp üzerinedir, tedavi edilmeyen çocuklarda fatal koroner arter anevrizmalarına neden olabilmektedir. Bu nedenle tanının erken konması, tedavinin zamanında ve uygun bir şekilde planlanması oldukça önemlidir. Bu derlemede ülkemizde de önemli bir morbidite nedeni olan Kawasaki hastalığının tanı, tedavi süreçleri ve prognostik özellikleri tartışılmıştır.

🔖

Cite This Article

AYKAN, H. H., ÖZKUTLU, S. (2017). Recent Advances in Kawasaki Disease. Abant Tıp Dergisi, Cilt: 6 - Sayı: 2, 77–85. https://ajindex.com/articles/440336

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi, 1967; 16:178-222
  2. Scuccimarri R. Kawasaki disease. Pediatr Clin North Am, 2012; 59:425-45
  3. Lin YT, Manlhiot C, Ching JC, Han RK, Nield LE, Dillenburg R, Pepelassis D, Lai LS, Smythe JF, Chahal N, Yeung RS, McCrindle BW. Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006. Pediatr Int, 2010; 52:699-706
  4. Ozen S, Bakkaloglu A, Dusunsel R, Soylemezoglu O, Ozaltin F, Poyrazoglu H, Kasapcopur O, Ozkaya O, Yalcinkaya F, Balat A, Kural N, Donmez O, Alpay H, Anarat A, Mir S, GurGuven A, Sonmez F, Gok F. Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol, 2007; 26:196-200
  5. Gulhan B, Kesici S, Beken S, Cilsal E, Kale G, Alehan D, Kara A, Ozen S. Varying clinical features of Turkish Kawasaki disease patients. Turk J Pediatr, 2012; 54:1-6
  6. Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, Kojo T, Uehara R, Kotani K, Yanagawa H. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol, 2015; 25:239-45
  7. Fujita Y, Nakamura Y, Sakata K, Hara N, Kobayashi M, Nagai M, Yanagawa H, Kawasaki T. Kawasaki disease in families. Pediatrics, 1989; 84:666-9
  8. De Ferranti SD, Newburger JW. Kawasaki disease (Mucocutaneous lymph node syndrome). In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF (eds). Moss and Adams heart disease in infants, children, and adolescents: including the fetus and young adult (8th ed). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2013
  9. Son MBF, Newburger JW. Kawasaki disease. In: Kliegman R, Stanton BF, St Geme JW, Schor NF (eds). Nelson textbook of pediatrics (20th ed). Philadelphia: Saunders, 2016
  10. Barron K, DeCunto C, Montalvo J, Orson F, Lewis D. Abnormalities of immunoregulation in Kawasaki syndrome. J Rheumatol, 1988; 15:1243-9
  11. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, Nakamura Y, Yanagawa H, Wakui K, Fukushima Y, Kishi F, Hamamoto K, Terai M, Sato Y, Ouchi K, Saji T, Nariai A, Kaburagi Y, Yoshikawa T, Suzuki K, Tanaka T, Nagai T, Cho H, Fujino A, Sekine A, Nakamichi R, Tsunoda T, Kawasaki T, Hata A. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet, 2008; 40:35-42
  12. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasak